Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): A randomized, controlled, multicenter phase III trial.
Geertjan van Tienhoven, Mustafa Suker(Erasmus MC Cancer Institute), Casper H.J. van Eijck(Erasmus MC), Judith de Vos‐Geelen(Maastricht University Medical Centre), Olivier R. Busch(Amsterdam Neuroscience), Gijs A. Patijn(Isala), Cornelis J.A. Punt(Utrecht University), Aeilko H. Zwinderman(Amsterdam Neuroscience), Bert A. Bonsing(Leiden University Medical Center), Karin Groothuis(Netherlands Comprehensive Cancer Organisation), Ignace H. J. T. de Hingh(Radboud University Nijmegen), Eva Versteijne(Cancer Center Amsterdam), Sebastiaan Festen(OLVG)
Cited by 161
Related Papers
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k
Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival
|Journal of Clinical Oncology|2008|1.4k
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k